Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5Gastrointestinal 5Other hematologic neoplasm 3Myeloid 3CNS 3Breast 3Other neoplasm 2Endocrine 2NET 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Lymphoma 2981Precursor Cell Lymphoblastic Leukemia-Lymphoma 2496Lymphoma, Non-Hodgkin 2265Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1847Lymphoma, Large B-Cell, Diffuse 1784Leukemia 1339Hodgkin Disease 1292Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 978Burkitt Lymphoma 955Multiple Myeloma 866Lymphoma, B-Cell, Marginal Zone 853Recurrence 839Lymphoma, B-Cell 754Myelodysplastic Syndromes 682Neoplasms 593Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 350Hematologic Neoplasms 350Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Processes × Lymphoid × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡